Concentra Group Holdings Parent upgraded by BofA Securities with a new price target
$CON
Medical Specialities
Health Care
BofA Securities upgraded Concentra Group Holdings Parent from Neutral to Buy and set a new price target of $24.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/16/2024 | $24.00 | Neutral → Buy | BofA Securities |
| 10/7/2024 | $30.50 → $24.00 | Buy → Neutral | BofA Securities |
| 8/20/2024 | $33.00 | Outperform | RBC Capital Mkts |
| 8/19/2024 | Buy | BofA Securities | |
| 8/19/2024 | $29.00 | Buy | Deutsche Bank |
| 8/19/2024 | $29.00 | Overweight | JP Morgan |
| 8/19/2024 | $32.00 | Buy | Goldman |
| 8/19/2024 | $28.00 | Outperform | Mizuho |
8-K - Concentra Group Holdings Parent, Inc. (0002014596) (Filer)
SCHEDULE 13G/A - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)
10-Q - Concentra Group Holdings Parent, Inc. (0002014596) (Filer)
4 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)
4 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)
4 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)